Mirae Asset Global Investments Co., Ltd. Abb Vie Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 679,875 shares of ABBV stock, worth $129 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
679,875
Previous 530,827
28.08%
Holding current value
$129 Million
Previous $105 Million
15.25%
% of portfolio
0.5%
Previous 0.47%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
3,894Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$32.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.95 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.36 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $336B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...